glp 1 agonist effects The cardiovascular of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action Clinical Recommendations to Manage Gastrointestinal
Description
After liraglutide 24 h urine sodium excretion increased in both groups vs
doi:10.3390/ijms19010026 81
Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
The majority of studies indicate that defective GLP-1 secretion does not appear to predate the development of glucose intolerance, rather diabetes itself seems to be associated with the acquired defect in GLP-1 secretion and GIP action [23]
